Lord, Abbett & Co. LLC Bluebird Bio, Inc. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $28.8 Million - $36.9 Million	-288,965 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $7.27 Million - $10.4 Million	-68,715 Reduced 19.21%	288,965 $49.3 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $8.95 Million - $14.4 Million	110,207 Added 44.53%	357,680 $63.7 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $14.3 Million - $22.6 Million	247,473	247,473 $34 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.